XML 60 R46.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Quarterly Data (Unaudited) (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2018 | Dec. 31, 2017
Quarterly Financial Information Disclosure [Abstract] |  |
Quarterly Data (Unaudited) Table |
|  | 2018
|  | First |  | Second |  | Third |  | Fourth |  | Total
|  | (In Millions, Except Per Share Data)
Net operating revenues |  | $ | 1,046.0 |  |  | $ | 1,067.7 |  |  | $ | 1,067.6 |  |  | $ | 1,096.0 |  |  | $ | 4,277.3 |
Operating earnings (a) |  | 150.0 |  |  | 157.3 |  |  | 154.5 |  |  | 93.4 |  |  | 555.2 |
Provision for income tax expense |  | 30.0 |  |  | 29.3 |  |  | 30.2 |  |  | 29.4 |  |  | 118.9 |
Income from continuing operations |  | 105.7 |  |  | 113.0 |  |  | 109.4 |  |  | 46.2 |  |  | 374.3 |
(Loss) income from discontinued operations, net of tax |  | (0.5 | ) |  | 0.2 |  |  | (0.1 | ) |  | 1.5 |  |  | 1.1 |
Net income |  | 105.2 |  |  | 113.2 |  |  | 109.3 |  |  | 47.7 |  |  | 375.4 |
Less: Net income attributable to noncontrolling interests |  | (21.4 | ) |  | (21.4 | ) |  | (20.7 | ) |  | (19.6 | ) |  | (83.1 | )
Net income attributable to Encompass Health |  | $ | 83.8 |  |  | $ | 91.8 |  |  | $ | 88.6 |  |  | $ | 28.1 |  |  | $ | 292.3 |
Earnings per common share: |  |  |  |  |  |  |  |  |  |
Basic earnings per share attributable to Encompass Health common shareholders: (b) |  |  |  |  |  |  |  |  |  |
Continuing operations |  | $ | 0.86 |  |  | $ | 0.93 |  |  | $ | 0.90 |  |  | $ | 0.27 |  |  | $ | 2.97 |
Discontinued operations |  | (0.01 | ) |  | — |  |  | — |  |  | 0.02 |  |  | 0.01 |
Net income |  | $ | 0.85 |  |  | $ | 0.93 |  |  | $ | 0.90 |  |  | $ | 0.29 |  |  | $ | 2.98 |
Diluted earnings per share attributable to Encompass Health common shareholders: (b) |  |  |  |  |  |  |  |  |  |
Continuing operations |  | $ | 0.85 |  |  | $ | 0.92 |  |  | $ | 0.89 |  |  | $ | 0.26 |  |  | $ | 2.92 |
Discontinued operations |  | (0.01 | ) |  | — |  |  | — |  |  | 0.02 |  |  | 0.01 |
Net income |  | $ | 0.84 |  |  | $ | 0.92 |  |  | $ | 0.89 |  |  | $ | 0.28 |  |  | $ | 2.93 |
(a) | We define operating earnings as income from continuing operations attributable to Encompass Health before (1) loss on early extinguishment of debt; (2) interest expense and amortization of debt discounts and fees; (3) other income; and (4) income tax expense.
(b) | Per share amounts may not sum due to the weighted average common shares outstanding during each quarter compared to the weighted average common shares outstanding during the entire year.
|  | 2017
|  | First |  | Second |  | Third |  | Fourth |  | Total
|  | (In Millions, Except Per Share Data)
Net operating revenues |  | $ | 957.1 |  |  | $ | 966.4 |  |  | $ | 981.6 |  |  | $ | 1,008.8 |  |  | $ | 3,913.9 |
Operating earnings (a) |  | 147.1 |  |  | 141.3 |  |  | 145.2 |  |  | 144.7 |  |  | 578.3 |
Provision for income tax expense (b) |  | 39.7 |  |  | 28.6 |  |  | 43.1 |  |  | 34.4 |  |  | 145.8 |
Income from continuing operations (b) |  | 84.7 |  |  | 79.2 |  |  | 85.2 |  |  | 101.5 |  |  | 350.6 |
(Loss) income from discontinued operations, net of tax |  | (0.3 | ) |  | 0.2 |  |  | (0.1 | ) |  | (0.2 | ) |  | (0.4 | )
Net income (b) |  | 84.4 |  |  | 79.4 |  |  | 85.1 |  |  | 101.3 |  |  | 350.2 |
Less: Net income attributable to noncontrolling interests |  | (17.6 | ) |  | (16.4 | ) |  | (19.2 | ) |  | (25.9 | ) |  | (79.1 | )
Net income attributable to Encompass Health (b) |  | $ | 66.8 |  |  | $ | 63.0 |  |  | $ | 65.9 |  |  | $ | 75.4 |  |  | $ | 271.1 |
Earnings per common share: |  |  |  |  |  |  |  |  |  |
Basic earnings per share attributable to Encompass Health common shareholders: (b) (c) |  |  |  |  |  |  |  |  |  |
Continuing operations |  | $ | 0.75 |  |  | $ | 0.70 |  |  | $ | 0.67 |  |  | $ | 0.77 |  |  | $ | 2.88 |
Discontinued operations |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Net income |  | $ | 0.75 |  |  | $ | 0.70 |  |  | $ | 0.67 |  |  | $ | 0.77 |  |  | $ | 2.88 |
Diluted earnings per share attributable to Encompass Health common shareholders: (b) (c) (d) |  |  |  |  |  |  |  |  |  |
Continuing operations |  | $ | 0.70 |  |  | $ | 0.70 |  |  | $ | 0.67 |  |  | $ | 0.76 |  |  | $ | 2.84 |
Discontinued operations |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Net income |  | $ | 0.70 |  |  | $ | 0.70 |  |  | $ | 0.67 |  |  | $ | 0.76 |  |  | $ | 2.84 |
(a) | We define operating earnings as income from continuing operations attributable to Encompass Health before (1) loss on early extinguishment of debt; (2) interest expense and amortization of debt discounts and fees; (3) other income; and (4) income tax expense.
(b) | During the preparation of our December 31, 2018 financial statements, an error was identified in the accounting for deferred tax assets as described further in Note 1, Summary of Significant Accounting Policies, “Revision of Previously Issued Financial Statements.” The financial results included in the table above reflects the revision of our quarterly results for the three months and year ended December 31, 2017 to reflect the $14.8 million reduction in our Provision for income tax expense as shown in the table below. The revision of unaudited financial statements for the quarter and year-to-date periods ended March 31, June 30, and September 30, 2018 related to the statement of shareholders’ equity, will be affected in connection with the filing of our 2019 Form 10-Qs.
| As Reported |  | Adjustment |  | As Revised
For the Three Months Ended December 31, 2017 | (In Millions, Except Per Share Data)
Provision for income tax expense | $ | 49.2 |  |  | $ | (14.8 | ) |  | $ | 34.4 |
Income from continuing operations | 86.7 |  |  | 14.8 |  |  | 101.5 |
Net income | 86.5 |  |  | 14.8 |  |  | 101.3 |
Net income attributable to Encompass Health | 60.6 |  |  | 14.8 |  |  | 75.4 |
Basic earnings per share attributable to Encompass Health common shareholders | 0.62 |  |  | 0.15 |  |  | 0.77 |
Diluted earnings per share attributable to Encompass Health common shareholders | 0.61 |  |  | 0.15 |  |  | 0.76 |
(c) | Per share amounts may not sum due to the weighted average common shares outstanding during each quarter compared to the weighted average common shares outstanding during the entire year.
(d) | For the second quarter of 2017, adding back the loss on extinguishment of convertible debt, net of tax to our Income from continuing operations attributable to Encompass Health common shareholders causes a per share increase when calculating diluted earnings per common share resulting in an antidilutive per share amount. Therefore, basic and diluted earnings per common share are the same for the three months ended June 30, 2017.

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=109225645&loc=d3e1280-108306 + Details
Name: | us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration